Filing Details
- Accession Number:
- 0001209191-17-006410
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-31 16:55:47
- Reporting Period:
- 2017-01-27
- Filing Date:
- 2017-01-31
- Accepted Time:
- 2017-01-31 16:55:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1412067 | Cascadian Therapeutics Inc. | CASC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1356256 | Dunseth Scott Myers | C/O Cascadian Therapeutics, Inc. 2601 4Th Ave., Suite 500 Seattle WA 98121 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-27 | 20,500 | $3.76 | 38,416 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $3.695 to $3.8435 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Effective as of November 29, 2016, the issuer effected a 6-for-1 reverse split of its common stock. The number of shares above reflects the reverse stock split.
Billionaire Hedge Funds
